ASP Isotopes Inc. (ASPI) · Oct 26, 2026 · Other events
Stable production achieved — Production achieved after prior Q3 target; first deliveries pending
ASP Isotopes says helium production is now stable after commissioning, moving Virginia Gas toward first contracted deliveries but missing its prior Q3 target.
ASP Isotopes is using its 2026 Renergen acquisition to turn the Virginia Gas Project into a commercial helium and LNG operation; before this filing, the company had targeted commercial helium production in the third quarter of 2026 and expected production before September 30.
The project has cleared its biggest technical hurdle. Tetra4 has completed commissioning and reached stable liquid helium production. 〔0〕 That is a real step up from earlier commissioning updates: the plant is now producing rather than merely being prepared to produce.
Commercialization is close, but not complete. Liquid helium is accumulating in storage under existing offtake agreements, while logistics for first deliveries are still being finalized. 〔1〕 The filing therefore validates the production process and contracted demand, but it does not yet show delivered product, recognized revenue, or cash generation.
The timing is the mixed part. Stable production arrives on October 26, 2026, after the company’s earlier target of commercial production by the end of the third quarter. The delay is modest relative to the milestone achieved, but it means the announcement is not a clean upside surprise. The company now expects to ramp to nameplate capacity during the fourth quarter of 2026. 〔2〕
The operating base is now clearer, though still forward-looking. Phase 1 is expected to produce approximately 2,500 GJ/day of LNG and approximately 70 Mcf/day of liquid helium once fully ramped. 〔3〕 Those are capacity targets, not current run-rate results, so the next proof point is whether production reaches those levels and converts into actual shipments.
Bottom line: This moves Virginia Gas from commissioning into genuine helium production, materially strengthening ASP Isotopes’ commercialization story. The still-pending first delivery and slippage from the prior Q3 target keep the read mixed rather than unequivocally positive.
First contracted helium deliveries and Q4 2026 nameplate ramp
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!